Annals of the rheumatic diseases 2018-05
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.
Related Questions
Does your approach differ based on the underlying condition - such as ANCA-associated vasculitis, rheumatoid arthritis, or another autoimmune disease?
New answer by at Duke University Medical Center (November 17, 2025)
Some experts suggest consideration of stopping PJP prophylaxis in lower risk patients once the steroid dosage is below prednisone 10-15mg daily (PMID 29459427). A patient stil...